A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

Recruiting

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(95 sites)

United States

Arizona Research Center, Phoenix, Arizona

AMR Clinical, Tempe, Arizona

Care Access - Huntington Beach, Huntington Beach, California

Care Access - Thousand Oaks, Thousand Oaks, California

Legacy Clinical Trials, Colorado Springs, Colorado